In the era of precision medicine and personalized therapies, the demand for custom active pharmaceutical ingredients (APIs) is rapidly increasing. As a global leader in CDMO (Contract Development and Manufacturing Organization) services, Litchlab specializes in high-end API synthesis and process optimization, offering end-to-end solutions for small molecules, nucleic acid-based drugs, peptides, antibody-drug conjugates (ADCs), advanced lipids, and PEGylated compounds.
API Type | Key Advantages | Application Areas |
Small Molecule APIs | Smart synthesis strategies for enhanced reaction efficiency and yield | Oncology, antiviral therapies, autoimmune diseases |
Nucleic Acid & Oligonucleotide APIs | High-purity synthesis for siRNA, mRNA, ASO applications | Gene therapy, RNA vaccines, rare diseases |
Peptides & Protein APIs | Advanced solid-phase and liquid-phase synthesis for high purity and activity | Diabetes, cardiovascular diseases, antimicrobial peptides |
ADC Linkers & Payloads | High-stability, high-selectivity conjugation technologies | Targeted cancer therapy, autoimmune diseases |
PEGylated APIs | Improved stability, solubility, and circulation half-life | mRNA vaccines, protein therapeutics, antibody drugs |
Advanced Lipid Synthesis | Optimized for LNP (Lipid Nanoparticle) drug delivery | mRNA vaccines, gene editing, liver disease treatments |
APIs are the core components of any drug, yet standardized APIs often fail to meet the unique requirements of innovative therapeutics. Leveraging expertise in organic synthesis, biocatalysis, and high-efficiency purification technologies, Litchlab provides fully customized API development, ensuring optimal solubility, bioavailability, targeted delivery, and metabolic stability for each specific application.
Litchlab operates state-of-the-art GMP-compliant facilities, adhering strictly to ICH Q7, FDA, EMA, and other global regulatory standards, ensuring every batch of API is highly pure, stable, and consistent.
Scalable Manufacturing – Supporting production from gram-scale to ton-scale for different drug development stages
Automated Flow Chemistry Systems – Reducing byproducts and increasing target compound yields
Rigorous Quality Control – Utilizing HPLC, MS, NMR, and other advanced techniques to ensure API compliance with the highest standards
In drug development, API stability, batch consistency, and process scalability are critical. Litchlab offers comprehensive CMC (Chemistry, Manufacturing, and Controls) support, covering process development, analytical method development, stability studies, and both clinical and commercial production, helping clients expedite IND (Investigational New Drug) and NDA (New Drug Application) submissions.
Precision Synthesis – Tailor-made to meet complex chemical structure requirements
Rapid Delivery – Flexible production systems to shorten R&D timelines
Global Regulatory Compliance – GMP-compliant manufacturing, adhering to FDA and EMA standards
End-to-End Support – From early-stage R&D to full-scale commercial manufacturing
Litchlab is committed to being a trusted API development partner for global pharmaceutical companies, accelerating the path to groundbreaking therapies!
For more information, please feel free to contact us at:
E-Mail:RD1@Litchlab.com
